Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-14T22:33:38.619Z Has data issue: false hasContentIssue false
  • English
  • Français

Tardive dyskinesia: screening and risk disclosure

Published online by Cambridge University Press:  02 January 2018

Robert Chaplin  and
Mark Potter
Robert Chaplin*
Affiliation:
Department of Mental Health Sciences, St George's Hospital, Medical School, Cranmer Terrace, London SW17 ORE
Mark Potter
Affiliation:
Department of Mental Health Sciences, St George's Hospital, Medical School, Cranmer Terrace, London SW17 ORE
*
∗Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A questionnaire was sent to a random sample of 339 psychiatrists on the Royal College mailing list, enquiring about their practice of screening and risk disclosure in patients at risk of tardive dyskinesia. The response rate was 70%. There was wide variation in the rate of informing patients of the risk. Over half of the respondents felt that knowledge about tardive dyskinesia would reduce compliance, a view which predicted a low rate of informing patients. There was support for the issuing of clinical practice guidelines by the College. Psychiatrists need further education about tardive dyskinesia.

Type
Original Papers
Information
Psychiatric Bulletin , Volume 20 , Issue 12 , December 1996 , pp. 714 - 716
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1996 The Royal College of Psychiatrists

References

Benjamin, S. & Munetz, M. R. (1994) Community mental health centre practices related to tardive dyskinesia screening and informed consent for neuroleptic drugs. Hospital and Community Psychiatry, 45, 343–346.Google Scholar
British Medical Journal Legal Correspondent (1985) What should a doctor tell. British Medical Journal 290, 780–781.Google Scholar
Brown, C. S., Wright, R. G. & Christensen, D. B. (1987) Association between type of medication instruction and patient's knowledge, side-effects and compliance. Hospital and Community Psychiatry, 38, 55–60.Google Scholar
Department of Health and Welsh Office (1993) Code of Practice 1993: Mental Health Act 1983. London: HMSO.Google Scholar
Guy, W. (1976) ECDEU Assessment Manual for Psychopathology. Washington, DC: US Department of Health, Education and Welfare.Google Scholar
Kane, J. M., Woerner, M., Weinhold, P., et al (1984) Incidence of tardive dyskinesia: Five year data from a prospective study. Psychopharmacology Bulletin, 20, 387–389.Google Scholar
Kleinman, I., Schachter, D. & Koritar, E. (1989) Informed consent and tardive dyskinesia. American Journal of Psychiatry, 146, 902–904.Google ScholarPubMed
Munetz, M. R. & Benjamin, S. (1990) Who should perform the AIMS examination. Hospital and Community Psychiatry, 41, 912–915.Google Scholar
Woerner, M., Kane, J. M., Lieberman, , et al (1991) The prevalence of tardive dyskinesia. Journal of Clinical Psychopharmacology, 11, 34–42.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.